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Matrix stiffness controls lymphatic vessel
formation through regulation of a GATA2-
dependent transcriptional program
Maike Frye1, Andrea Taddei2, Cathrin Dierkes3, Ines Martinez-Corral 1, Matthew Fielden4, Henrik Ortsäter1,
Jan Kazenwadel5, Dinis P. Calado2, Pia Ostergaard 6, Marjo Salminen7, Liqun He8, Natasha L. Harvey5,
Friedemann Kiefer3,9 & Taija Mäkinen1
Tissue and vessel wall stiffening alters endothelial cell properties and contributes to vascular
dysfunction. However, whether extracellular matrix (ECM) stiffness impacts vascular
development is not known. Here we show that matrix stiffness controls lymphatic vascular
morphogenesis. Atomic force microscopy measurements in mouse embryos reveal that
venous lymphatic endothelial cell (LEC) progenitors experience a decrease in substrate
stiffness upon migration out of the cardinal vein, which induces a GATA2-dependent tran-
scriptional program required to form the ﬁrst lymphatic vessels. Transcriptome analysis
shows that LECs grown on a soft matrix exhibit increased GATA2 expression and a GATA2-
dependent upregulation of genes involved in cell migration and lymphangiogenesis, including
VEGFR3. Analyses of mouse models demonstrate a cell-autonomous function of GATA2 in
regulating LEC responsiveness to VEGF-C and in controlling LEC migration and sprouting
in vivo. Our study thus uncovers a mechanism by which ECM stiffness dictates the migratory
behavior of LECs during early lymphatic development.
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Cells are exposed to different types of mechanical forcessuch as shear, stretch and matrix stiffness that synergizewith chemical cues to regulate cell behavior and fate
during development and homeostasis1. Cells recognize and
respond to these physical stimuli through their cell–cell and
cell–matrix adhesions and translate the mechanical information
into biological responses in a process called mechanotransduc-
tion. For example, extracellular matrix (ECM) stiffness regulates
the differentiation of multipotent mesenchymal stem cells. Rigid
matrices mimicking bone were found to be osteogenic while soft
matrices mimicking brain were neurogenic2. Substrate stiffness is
also a critical determinant of the ability of stem cells to self-
renew3. Besides inﬂuencing cell fate and behavior at the single cell
level, ECM stiffness can regulate tissue morphogenesis4,5. This is
exempliﬁed by soft matrix driven spatial organization of germ
layers during gastrulation5. Physical properties of tissues often
change in disease. ECM stiffness has been consequently shown to
contribute to various diseases including tissue ﬁbrosis, as well as
cancer progression by changing cancer and stromal cell
functions6,7.
Endothelial cells (ECs) comprise the inner layer of blood and
lymphatic vessels. ECs are surrounded by an extracellular base-
ment membrane (BM) that provides physical and chemical gui-
dance cues for the formation and stabilization of vessel
networks8. Together with the interstitial matrix (IM), which
comprises the interstitial space between all cell types, the BM
forms the ECM. The composition and mechanical properties of
the ECM differ across the vascular tree, in its surrounding tissues
and at different stages of development. The role of speciﬁc ECM
molecules in vascular development has been studied, and tissue
and vessel wall stiffening has been shown to alter endothelial
behavior and contribute to vascular dysfunction in disease9.
However, it is not known if and how ECM stiffness inﬂuences
vascular morphogenesis. In vitro studies demonstrate that soft
matrices induce profound changes in EC shape and behavior by
promoting cell elongation, sprouting and capillary network for-
mation, independently of exogenous growth factors10,11. Like
most adherent cells, ECs respond to soft matrix by reduced
proliferation12. Key regulators of cell responses to mechanical
cues are the YAP and TAZ transcription factors that localize to
nucleus and activate targets upon mechanical stimulus, such as
stiff ECM, stretching or shear. YAP and TAZ promote cell pro-
liferation in most cell types, including ECs13–15. Interestingly, a
speciﬁc role for TAZ was identiﬁed in lymphatic endothelial cells
(LECs) in controlling their response to oscillatory shear stress
(OSS), which provides a stimulus for the initiation of luminal
valve formation16. OSS induces LEC quiescence through FOXC2
induction, and loss of FOXC2 leads to TAZ-dependent cell cycle
entry and defective valve morphogenesis14,16. Although both ﬂuid
shear stress and stiffening of the ECM activate mechanosignalling
in the EC, it is not known to what extent the cellular responses to
the two stimuli are shared.
Here we uncover a novel mechanism by which matrix stiffness
controls the critical early step of lymphatic vascular morpho-
genesis when LEC progenitors delaminate from the cardinal vein
and migrate to the surrounding tissue to form the ﬁrst lymphatic
vessels. We identify the GATA2 transcription factor as a critical
regulator of matrix stiffness induced transcriptional program in
the LECs. As opposed to the previously reported activation of
GATA2 by increased mechanical stimulus upon exposure of
BECs or LECs to stiff matrix or oscillatory ﬂow, respectively17–19,
we found that GATA2 expression is increased in LECs grown on
a soft matrix. We further show that GATA2 is required for early
lymphatic vascular morphogenesis by controlling lymphangio-
genic growth factor responsiveness following the exposure of
migrating venous-derived LECs to a soft embryonic tissue.
Results
Venous LEC progenitors experience soft matrix outside the
CV. The ﬁrst lymphatic vessels form through transdifferentiation
of venous to lymphatic ECs followed by their migration out of
certain major veins such as the cardinal vein (CV)20,21. Venous
ECs including the venous LEC progenitors expressing the PROX1
transcription factor are tightly attached to the underlying base-
ment membrane and show a ﬂattened spread out morphology. In
contrast, upon exiting the CV LEC progenitors form a network of
cells that exhibit a spindle-like shape and elongated nucleus20
(Fig. 1a). Rigid matrices have been shown to support
cell–substrate attachment and cell spreading, while soft matrices
promote cell–cell connectivity and endothelial network forma-
tion10. We therefore hypothesized that the observed change in cell
shape and organization reﬂects exposure of migrating LECs to a
softer matrix.
To visualize the mechanical properties of the ECM in vivo, we
analyzed deposition of collagen I, which is the predominant
collagen type of the ECM and contributes to determining tissue
stiffness in the embryo4,22. Analysis of immunostained transverse
vibratome sections of E11 embryos showed an overall low level of
collagen I (Fig. 1b). Arteries and blood capillaries exhibited the
highest collagen I density, while CV and the migrating LECs
showed moderate or low collagen I, respectively (Fig. 1b, c). ECM
stiffness regulates cell shape but also the morphology and
structure of the nucleus23. On soft matrix, nuclear lamina is
distorted and wrinkled, whereas on stiff matrix nuclear distor-
tions are smoothened out24. Staining of E11 embryos for LaminB,
the major component of the nuclear lamina25, showed higher
nuclear circularity (i.e. lower distortion) in ECs of the CV
compared to cells in the surrounding avascular tissue (Fig. 1d, e).
For a more precise measurement of tissue stiffness, we
performed ex vivo atomic force microscopy (AFM). The position
of the CV and area of the future lymphatic plexus were located
using a ﬂuorescence microscope in freshly prepared 350 µm
sections of E11 Prox1-GFP+ embryos based on GFP ﬂuorescence
in the CV as well as the spinal cord and the dorsal root ganglia.
The stiffness of the tissue was determined via AFM-based
indentation measurement with a pyramidal tip, allowing the
values of the effective Young’s modulus to be calculated. The CV
showed a 13-fold higher stiffness with a Young’s modulus of 3.6
± 0.04 kPa compared to 0.27 ± 0.01 kPa in the surrounding tissue
(Fig. 1f). The latter values match those measured in early chicken
embryos (0.3 kPa)4 and adult brain (0.33 kPa)26, but are
signiﬁcantly lower compared to values from most other adult
tissues including muscle (8–17 kPa) or bone (25–40 kPa)2, or
tissue culture plastic or glass (gigapascal range)27.
Collectively, these results demonstrate that venous LEC
progenitors experience a dramatic 13-fold decrease in matrix
stiffness during a critical early step in development when they
delaminate from the CV and migrate to the surrounding tissue to
form the ﬁrst lymphatic structures. ECM mechanosensing may
thus play an important role in regulating LEC phenotype and
behavior during early lymphatic development.
The transcription factor GATA2 is upregulated on soft matrix.
To identify regulators of LEC response to matrix stiffness, we
analyzed global transcriptional changes in primary human dermal
LECs seeded on stiff (25 kPa) or soft (0.2 kPa) matrices. Affy-
metrix GeneChip analysis revealed regulation of 2771 transcripts
above or below a 1.4-fold change (log2 fold change > 0.5 or <
−0.5) threshold on soft versus stiff matrices. We focused on the
162 regulated transcription factors (TFs) of which the potential
core TFs controlling LEC response to matrix stiffness were pre-
dicted based on up- and downregulated genes with the online
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resource TFactS28 (Supplementary Data 1). These included the
mechanosensitive GATA2 transcription factor that was pre-
viously shown to regulate the LEC response to shear stress18,19,
and respond to ECM-derived mechanical signals in blood ECs
(BECs) by changing its nuclear/cytoplasmic localization17. Fur-
thermore, GATA2 has been identiﬁed as a causative gene for
Emberger syndrome, a form of primary lymphedema with
myelodysplasia (OMIM #614038)29,30, and a critical regulator of
lymphatic valve formation18.
Quantitative real time (RT)-PCR analysis of human (Fig. 2a)
and mouse (Fig. 2b) primary dermal LECs seeded on soft (0.2
kPa) in comparison to stiff (25 kPa) matrices validated the array
data and showed a 2-fold increase in GATA2 mRNA levels.
Similar results were observed when analyzing human LECs
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Fig. 1 Venous LEC progenitors experience lower matrix stiffness upon migration out of the cardinal vein. a, b Immunoﬂuorescence of sagittal (a) and
transverse (b) vibratome sections of E11 Prox1-GFP embryos using antibodies against PROX1 (magenta), GFP (green, Prox1 reporter) and Collagen I (single
channel images in B only). In a, note the round nuclear shape of PROX1+ LECs in the cardinal vein (CV) (arrows) compared to elongated nuclei of the
migrating PROX1+ LECs (arrowheads) in the surrounding tissue. In b, aorta (A) and blood capillaries (BC) show higher Collagen I levels compared to CV
(arrow) and migrating LECs (arrowheads). c Quantiﬁcation of Collagen I density in the respective vessel types and avascular tissue in E11 embryos. Data
represent mean integrated density values of corrected total cell ﬂuorescence ± s.e.m. (unpaired Student’s t-test) quantiﬁed from n= 10 images taken from
two embryos. d Immunoﬂuorescence of transverse vibratome sections of E11 wild type embryos using antibodies against Emcn (magenta; marker of venous
EC) and LaminB (green, marker of nuclear envelope). Single plane image for LaminB staining is shown as a close-up (grey). Nuclear morphology is distorted
in cells outside the CV (arrow), as opposed to a round morphology in cells of the CV vessel wall (arrowhead). e Quantiﬁcation of nuclear circularity of
Emcn+ venous ECs (CV wall) and Emcn− cells of the surrounding tissue (outside CV). Horizontal lines represent mean (n= 30 (CV wall) and n= 34
(outside CV) from two embryos). p value, unpaired Student’s t-test. f Ex vivo AFM measurements (graph on the left) in transverse vibratome sections
(image on the right) of E11 Prox1-GFP embryos. Young’s Modulus (kPa) is a measure for the actual tissue stiffness. Horizontal lines represent mean (n= 10
measurements from one embryo (CV) and n= 114 measurements from three embryos (outside CV)). p value, unpaired Student’s t-test. Measurements
were done on the dorsal side of the CV (arrow) and the area of LEC migration (boxed area, outside CV). Prox1-GFP+ spinal cord (SC), dorsal root ganglion
(DRG) and nerve (N) were used for orientation. Scale bars: 100 µm
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seeded on matrices of 0.2 kPa in comparison to those of kPa
stiffness representing the physiological stiffness of the embryonic
CV (Supplementary Fig. 1a). In agreement with observations in
the BECs17, GATA2 showed a predominantly nuclear localization
in LECs seeded on matrices stiffer than 4 kPa (Fig. 2c,
Supplementary Fig. 1b). However, unlike in the BECs, GATA2
was not excluded from the nucleus of LECs grown on soft
matrices (Fig. 2c). Instead, GATA2 protein levels were increased
approximately 2-fold in both the nucleus (1.8-fold) and the
cytoplasm (2.1-fold) of LECs grown on soft matrix (Fig. 2c, d).
GATA2 is upregulated in LECs that migrate out of the CV. To
investigate if GATA2 is functionally important during migration
of LEC progenitors, we ﬁrst analyzed its expression in vivo in ECs
of the CV and forming lymphatic vessels. To this end, we dis-
sected jugular regions of E11 embryos carrying the Prox1-GFP
transgene that labels ECs within the CV, including LEC pro-
genitors, as well as LECs outside of the CV (Fig. 1a). The latter
were further identiﬁed by the expression of PDPN20. mRNA
expression in sorted ECs was normalized to the pan-endothelial
marker Tek, which was not regulated in LECs by matrix stiffness
(Supplementary Fig. 1c). As expected, Prox1-GFP+PDPN+ ECs
showed a strong increase in the expression of the LEC markers
Vegfr3 and Pdpn when compared to the expression in Prox1-
GFP+PDPN− ECs (Fig. 3a). Gata2 levels were also increased in
the PDPN+ LECs by 2.5-fold (Fig. 3a). Expression of the
pan-endothelial marker Erg was not changed (Fig. 3a).
GATA2 protein expression was further assessed by immunos-
taining of transverse cryo sections of E11 embryos. Staining
intensity was quantiﬁed after masking the Prox1-GFP signal to
extract the endothelial GATA2 and VEGFR3 signals. As
previously reported20,31, VEGFR3 was highly expressed in LECs
outside of the CV, showing a 2-fold increase in signal intensity
compared to ECs within the CV (Fig. 3b). GATA2 immunostain-
ing intensity was 1.9-fold higher in Prox1-GFP+VEGFR3high
LECs outside of the CV compared to Prox1-GFP+VEGFR3low
ECs within the CV (Fig. 3c).
Together, these in vitro and in vivo data demonstrate that
GATA2 mRNA and protein levels are increased upon exposure of
LECs to a soft matrix and when leaving the CV, which makes
GATA2 a candidate gene to regulate early lymphatic vascular
development.
GATA2 is required for LEC emigration from the veins. After
migrating out of the CV, LECs assemble in the jugular region of
the embryo into the ﬁrst primitive vessels, the primordial thoracic
ducts (pTD) and the peripheral longitudinal lymphatic vessels
(PLLV)20, from which most peripheral lymphatic vascular beds
form by vessel sprouting. In order to investigate the potential role
of GATA2 in these early steps of lymphatic development, we
deleted it in the BECs prior to LEC commitment using the Tie2-
Cre mice in combination with the ﬂoxed Gata2 allele (Fig. 3d).
Analysis of immunostained transverse vibratome sections of
E12.5 embryos revealed PROX1+ pTD and PLLV (commonly
referred to as ‘jugular lymph sac’)20, that were consistently
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Fig. 2 GATA2 regulation by matrix stiffness in LECs. a, b qRT-PCR analysis of GATA2 in human LECs (a) and primary mouse LECs (b) grown on soft (0.2
kPa) or stiff (25 kPa) matrix. n= 3 experiments, mean ± s.e.m. p value, one-sample t-test. c Immunoﬂuorescence of human LECs grown on stiff and soft
matrix using antibodies against GATA2 (green) and VE-cadherin (red), and for DAPI to show nuclei (grey). LECs grown on soft matrix exhibit an overall
higher expression of GATA2 as indicated by higher immunoﬂuorescence intensity in both the nucleus and cytoplasm and have an elongated shape and a
distorted nucleus. d Quantiﬁcation of nuclear and cytoplasmic GATA2 protein in human LECs grown on soft (0.2 kPa) or stiff (25 kPa) matrix. Data
represent mean pixel intensity (n= 8 images with 8–24 cells per image (soft), and n= 8 images with 21–37 cells per image (stiff) from 3 experiments) ± s.
e.m. p value, unpaired Student’s t-test. Scale bars: 50 µm
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smaller in Gata2ﬂox/ﬂox;Tie2-Cre in comparison to control
embryos (Fig. 3e, Supplementary Fig. 2a). Light-sheet microscopy
analysis of whole embryos further revealed rudimentary or mal-
formed pTD and PLLV, and reduced number of superﬁcial
lymphatic sprouts in Gata2 deﬁcient embryos (Fig. 3f, Supple-
mentary Fig. 2b, Supplementary Movies 1 and 2). All mutant
embryos analyzed (n= 4) also showed abnormal or absent dual
lymphovenous valves and blood inside the pTD (Fig. 3f, Sup-
plementary Fig. 2b). Consistent with reduced initial sprouting of
LECs, lymphatic vessels were absent from the cervical skin of
E13.5 Gata2ﬂox/ﬂox;Tie2-Cre embryos (Fig. 3g). Although early
blood vessel formation appeared to occur normally in the mutant
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embryos (Fig. 3e, e), at E13.5 Gata2ﬂox/ﬂox;Tie2-Cre showed
hemorrhaging and dilation of dermal blood vessels (Fig. 3g). They
died by E14.5 likely due to a combination of defects in both blood
and lymphatic vessels, as well as the hematopoietic compartment
that is also targeted by the Tie2-Cre transgene.
Accumulation of PROX1+ cells within and adjacent to cardinal
veins suggested arrested LEC migration in Gata2 deﬁcient
embryos (Fig. 3e, Supplementary Fig. 2b). Interestingly, Gata2-
ﬂox/ﬂox;Tie2-Cre embryos showed normal expression of the master
LEC fate regulator PROX1 in the pTD/PLLV (Fig. 3e, e,
Supplementary Fig. 2b), as well as downregulation of BEC
markers including Endomucin (Emcn) (Fig. 3e). This demon-
strates that loss of Gata2 does not prevent LEC differentiation but
inhibits migration of venous-derived LEC progenitors.
GATA2 regulates a stiffness-induced transcriptional program.
We next sought to analyze the role of GATA2 in regulating the
matrix stiffness-induced response in LECs by comparing the
transcriptomes of human LECs seeded on stiff or soft matrices in
the presence or absence of GATA2 (Fig. 4a). The expression of
406 (27%) of the 1485 transcripts that were increased and 207
(16%) of the 1286 transcripts that were decreased on soft matrix
was affected by GATA2 depletion (Fig. 4a). As expected13,
microarray analysis (Fig. 4b), and veriﬁcation by RT-qPCR from
two independent experiments (Fig. 4c), showed that exposure of
LECs to a soft matrix induced downregulation of proliferation
markers (CCNB1, CCNB2, CCNA2) and the established YAP/
TAZ targets (CTGF, ANKRD1). Gene Ontology (GO) analysis
further demonstrated soft matrix induced down-regulation of
genes encoding regulators of the cell cycle and cell division
(Fig. 4d), but enrichment of genes encoding molecules involved in
cell–matrix adhesion and junctional organization (Fig. 4d). LECs
grown on soft matrix also showed increase in GATA2-regulated
expression of genes involved in cell migration (GO terms high-
lighted in red in Fig. 4d) and vascular development, including the
known lymphatic regulators FLT4/VEGFR332, EFNB233,
ITGA934, and NOTCH135,36 and its targets HEY1 and HEY2
(Fig. 4b). GATA2 regulated GO terms and their associated genes
are depicted in Supplementary Fig. 3. Array data indicated that
mRNA levels of the endothelial junctional molecules VE-cadherin
and Claudin 5 were not altered. Veriﬁcation by RT-qPCR from
two independent experiments conﬁrmed GATA2-dependent
regulation of selected TOP genes, as indicated by abrogated or
reduced soft matrix induced up- or downregulation of selected
genes in GATA2 siRNA treated samples (Fig. 4e). Proliferation
markers (CCNB2, MIK67, MYBL2, BUB1) and YAP/TAZ target
genes (CTGF, CYR61) were not regulated by GATA2 (Supple-
mentary Fig. 3b). In addition, although reduced baseline
expression of YAP/TAZ target ANKRD1 in GATA2 siRNA
treated samples suggests its general regulation by GATA2, soft
matrix-induced downregulation still occurred (Supplementary
Fig. 3b). In summary, these results indicate an important role of
GATA2 in regulating soft matrix-induced transcriptional
response controlling migration, but not the general mechan-
oresponse in LECs.
GATA2 controls LEC responsiveness to VEGF-C. To study the
GATA2 regulated transcriptional program in LECs in vivo, we
conditionally deleted Gata2 in mouse using the tamoxifen-
inducible Vegfr3-CreERT2 line that efﬁciently targets both venous
and non-venous-derived dermal LECs37. Gene deletion was
induced prior to initiation of dermal lymphatic vessel formation
by administration of 4-hydroxytamoxifen (4-OHT) from E11.5.
Quantitative RT-PCR analysis of LECs isolated by ﬂow cytometry
from dorsal skins of E15.5 embryos showed downregulation of
the identiﬁed matrix stiffness regulated genes Vegfr3, Efnb2 and
Fgfr3 in Gata2ﬂox/ﬂox;Vegfr3-CreERT2 mice (Fig. 5a, Supplemen-
tary Fig. 4).
Next, we focused on the GATA2-dependent regulation of the
major lymphangiogenic growth factor receptor VEGFR3, the
activity of which has to be tightly controlled to ensure normal
lymphatic development38. In agreement with the array data, qRT-
PCR analysis showed that increased GATA2 expression in human
primary LECs seeded on soft in comparison to stiff matrix was
associated with a concomitant increase in VEGFR3 mRNA
expression (Fig. 5b, c). This was dependent on GATA2, since
GATA2 silencing abrogated soft matrix-induced VEGFR3 upre-
gulation (Fig. 5c).
To determine if GATA2 directly regulates VEGFR3 expression,
we performed ChIPseq in human dermal LECs. One pronounced
peak within a region covering the FLT4 gene (encoding VEGFR3)
and up to 50 kb upstream of the FLT4 promoter was identiﬁed
(Fig. 5d, Supplementary Fig. 5). The GATA2 binding peak
mapped to intron 1 of FLT4 and co-localized with two indicators
of active enhancer elements, H3K27Ac peak and a DNase
hypersensitivity site (Fig. 5d). These data suggest that GATA2
regulates VEGFR3 expression in LECs by directly binding to a site
in intron 1 of FLT4.
To assess the functional consequence of Gata2 loss on the
responsiveness of LECs to the VEGFR3 ligand VEGF-C, we
employed an in vitro sprouting assay. We isolated primary mouse
dermal LECs isolated from the Gata2ﬂox/ﬂox;Vegfr3-CreERT2 mice
that showed successful in vitro deletion of Gata2 and a decrease
in the baseline expression levels of VEGFR3 upon 4-OHT
treatment (Fig. 5e). VEGF-C induced sprout formation in vehicle
treated control cells while Gata2-deleted LECs failed to sprout in
response to VEGF-C (Fig. 5f–h).
Fig. 3 Defective migration of venous-derived LEC progenitors upon loss of endothelial Gata2 expression. a Relative expression levels of Gata2, the LEC
markers Vegfr3 and Pdpn and the pan-endothelial marker Erg in ECs within the CV (Prox1-GFP+PDPN−) compared to LECs outside of the CV (Prox1-
GFP+PDPN+). ECs were freshly isolated from E11 Prox1-GFP embryos (n= 3 independent samples with 4 pooled embryos in each, from two different
litters). Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. b Immunoﬂuorescence of transverse cryosections of E11 embryos using
antibodies against GFP (green; Prox1-GFP), GATA2 (magenta) and VEGFR3 (red). Single channel images are shown. The IMARIS surface mask depicts in
yellow the surface area used to extract GATA2 and VEGFR3 signal intensity. The surface mask was generated based on Prox1-GFP expression of VEGFR3+
LECs within and outside of the CV. c Quantiﬁcation of GATA2 and VEGFR3 staining intensity in ECs within (n= 35) and outside (n= 37 measurements) of
the CV. Data represent mean ± s.e.m. p value, unpaired Student’s t-test. d Schematic of the genetic constructs and analyzed embryonic stages. The time
frames for pTD+ PLLV (i.e. ‘jugular lymph sac’) and dermal lymphatic vessel formation are indicated. e Immunoﬂuorescence of transverse vibratome
sections of E12.5 embryos using antibodies against PROX1 (green) and Emcn (red; marker of venous EC). Single channel images for Emcn staining are
shown. Note smaller jugular lymph sac (JLS) and the presence of PROX1+ Emcn− LECs (arrowhead) within the CV in the mutant embryo. f Maximum
intensity projections of E12.5 embryos (sagittal view) stained whole-mount for indicated proteins and imaged using light sheet microscopy. Single channel
images for PROX1 staining are shown. Arrowheads point to lymphovenous valves that are deformed in the mutant embryos. g E13.5 embryos (panels on
the right) and whole-mount upper thoracic dorsal skin stained for Nrp2 (green) and Emcn (red). Nrp2+ dermal lymphatic vessels are absent in the mutant.
Scale bars: 20 μm (b) 100 μm (e, f, g skins), 1 mm (g, embryos)
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Together, these results demonstrate that matrix stiffness
induced increase in GATA2 levels promotes LEC responsiveness
to the major lymphangiogenic growth factor VEGF-C via
regulation of VEGFR3 expression.
GATA2 is required for dermal lymphatic vessel sprouting. The
VEGF-C/VEGFR3 pathway regulates lymphangiogenic growth
during all developmental stages39. We therefore asked if GATA2
has a general role in regulating VEGFR3 expression and signaling,
which could underlie dysfunction of dermal lymphatic vessels in
Emberger syndrome30. We analyzed dermal lymphatic vessel
sprouting in Gata2ﬂox/ﬂox;Vegfr3-CreERT2 mice at E15.5, when
non-venous derived LECs have incorporated into vessels, and at
E17.5, when the laterally extending vessel sprouts reach the dorsal
a
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midline37 (Fig. 6a). As expected, Gata2-deﬁcient lymphatic ves-
sels showed downregulation of VEGFR3 at both stages analyzed
(Fig. 6b). At E15.5, vessel diameter in the mutants was reduced
(Fig. 6d) while vessel branching, which showed a high inter-
individual variability likely due to rapid development of the
vasculature at this stage, was not altered (Fig. 6e). E17.5 Gata2
deﬁcient embryos exhibited a failure in the extension of lym-
phatic sprouts to the dorsal midline (Fig. 6c, f). The mutant
embryos also exhibited decreased vessel branching with a con-
comitant increase in the diameter of lymphatic vessels (Fig. 6d,e),
suggesting a defect in LEC migration. In agreement with this,
Gata2 deﬁcient sprouts displayed a blunted morphology and
reduced ﬁlopodia numbers and length (Fig. 6g-i). As previously
reported18, Gata2 deﬁcient vessels also lacked lymphatic valves
that develop during late stages of embryogenesis (Fig. 6c). Neither
the total number of LECs (Fig. 6j), nor the expression of pro-
liferation markers Mki67 and Ccnb1 (Fig. 6k) was altered in the
Gata2 mutant skin and sorted dermal LECs, respectively, in
comparison to control littermates. These data suggest that
defective LEC migration but not proliferation underlies lymphatic
vascular defects in the Gata2-deﬁcient embryos.
We further investigated the LEC autonomous function of
GATA2 by utilizing the Prox1-CreERT2 line (Supplementary
Fig. 6a). Unlike the Gata2ﬂox/ﬂox;Vegfr3-CreERT2 embryos, the
majority (3 out of 5) of the Gata2ﬂox/ﬂox;Prox1-CreERT2 embryos
showed subcutaneous edema (Supplementary Fig. 6b). 2 out of 3
edematous embryos also showed blood inside the dermal
lymphatic vessels. This is likely due to highly efﬁcient Prox1-
CreERT2 mediated targeting of the lymphovenous valves34 that
are critical for preventing blood from entering the lymphatic
system40,41 and are affected by Gata2 loss18 (Fig. 3c). Similar to
the Gata2ﬂox/ﬂox;Vegfr3-CreERT2 embryos at E17.5, Gata2ﬂox/ﬂox;
Prox1-CreERT2 showed decreased vessel branching, increased
vessel diameter, and blunted vessel sprouts with reduced number
of ﬁlopodia (Supplementary Fig. 6c-f). The earlier onset of the
phenotype in the Prox1-CreERT2 in comparison to the Vegfr3-
CreERT2 model may reﬂect different efﬁciencies of gene deletion.
However, non-LEC autonomous effects due to edema and blood
ﬁlling of lymphatic vessels in the Gata2ﬂox/ﬂox;Prox1-CreERT2
embryos cannot be ruled out.
Taken together, these results demonstrate a LEC-autonomous
function of GATA2 in modulating lymphangiogenic growth
factor responsiveness of LECs and controlling dermal lymphatic
vessel sprouting and patterning.
LECs respond differently to matrix stiffness and OSS. The
above results reveal matrix-stiffness induced activation of a
GATA2-regulated transcriptional program in LECs in response to
decreased mechanical stimulus (soft matrix). Conversely,
increased mechanical stimulus triggered by oscillatory ﬂow,
which provides a signal for the initiation of valve morphogenesis
at vessel branch points16, increases GATA2 levels and GATA2-
dependent expression of key regulators of valve morphogenesis18.
In order to deﬁne whether the transcriptional control mechan-
isms of these GATA2-dependent mechanosensitive steps of
lymphatic vascular morphogenesis are shared, we compared
stiffness-induced gene expression changes on soft matrix to those
previously shown to be induced by oscillatory shear stress (OSS)
14. Consistent with the observed cell cycle arrest by both stimuli
(Fig. 4c)14,42, we found among downregulated transcripts
enrichment of genes involved in cell proliferation, including those
encoding the Cyclin and Kinesin superfamily proteins (Fig. 7a).
However, only a small proportion of genes overall were regulated
similarly by soft matrix and OSS. GO analysis of the upregulated
transcripts showed enrichment of genes controlling vascular
development and cell migration. Notably, matrix metalloprotei-
nase (MMP) signalling components (MMP1, MMP2 and
MMP10), implicated as positive regulators of lymphangiogen-
esis43,44, were upregulated both by exposure of LECs to soft
matrix or OSS. OSS, but not soft matrix exposure also led to
highly signiﬁcant enrichment of upregulated genes associated
with metabolic processes.
Differential transcriptional responses to soft matrix and OSS
exposure, although partly controlled by GATA2, may not be
entirely unexpected given the opposite effects of the two stimuli
on the general YAP/TAZ dependent mechanotransduction path-
way. We therefore asked if the transcriptional responses to
increased mechanical stimuli by stiffer matrix and OSS are
shared. As expected, LECs exposed to stiff matrix or OSS showed
increased expression of the YAP/TAZ target gene CTGF
(Supplementary Fig. 7). However, only a small subset of high
stiffness-regulated genes (8%), mostly implicated in cell adhesion
and locomotion, showed a similar down- or upregulation,
respectively, by OSS, suggesting unique mechanoresponses in
LECs to different stimuli.
Discussion
Tissue mechanics are known to regulate morphogenetic pro-
cesses, but the effect of ECM stiffness on vascular development,
and how mechanical forces resulting from differential matrix
stiffness translate into intracellular signals in ECs are poorly
understood. In this study, we uncover a role for the GATA2
transcription factor in controlling lymphangiogenic growth factor
responsiveness in venous-derived LECs as they move from a
stiffer environment in the cardinal vein wall to a softer matrix
outside of the cardinal vein. We further identify an important role
of GATA2 in regulating baseline VEGFR3 expression levels, and
thereby LEC migration and lymphatic vessels growth, also at later
stages of development.
Early stages of lymphatic development require PROX1 and
VEGF-C/VEGFR3 that regulate LEC differentiation and migra-
tion out of the veins, respectively31,45. A positive feedback loop
between PROX1 and VEGFR3 was identiﬁed as a key mechanism
controlling the identity and number of venous-derived LEC
progenitors46. Our data show that in the absence of GATA2,
PROX1 is not sufﬁcient to confer LEC responsiveness to VEGF-C
Fig. 4 GATA2 regulates a matrix stiffness-induced transcriptional program in the LECs. a Schematic overview of microarray gene expression analysis
comparing Ctrl and GATA2 siRNA-treated human LECs grown on stiff (25 kPa) or soft (0.2 kPa) matrix. Number of genes regulated by matrix stiffness (n=
6 biological replicates) and the proportion of those showing GATA2-regulated expression (n= 2 biological replicates) are shown. b Selected TOP genes
that are upregulated or downregulated on soft (0.2 kPa) in comparison to stiff (25 kPa) matrix and affected by GATA2 depletion. Heatmap color coding
shows maximum for log2 fold change >1 or <−1. c Veriﬁcation of microarray data in 2 additional independent experiments by qRT-PCR analysis shows the
expected downregulation of markers of proliferation (CCNB1) and YAP/TAZ dependent mechanosignalling (CTGF, ANKRD1) in LECs grown on soft matrix.
d Selected signiﬁcantly enriched GO terms in LECs grown on soft matrix. The fold enrichment of upregulated (red bars) and downregulated (green bars) is
shown. Genes associated with cell–matrix adhesion, cell migration and vascular development are upregulated on soft matrix, whereas genes associated
with cell proliferation are downregulated. Notably, GO terms associated with cell migration, locomotion and motility (highlighted in red) are upregulated in
a GATA2 dependent manner. e Veriﬁcation of selected matrix stiffness regulated genes from the microarray expression analysis by qRT-PCR analysis in
two independent experiments. Horizontal lines represent mean
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in vitro or in vivo. On the other hand, GATA2 function was not
required for PROX1 expression and LEC differentiation. The
GATA2-dependent regulation of genes involved in cell migration
and lymphangiogenesis, including VEGFR3, but not those encoding
general regulators of LECmechanoresponse to soft matrix, points to
a speciﬁc role of GATA2 in controlling the migratory behavior of
LECs. In support of this, we show that GATA2 is required in vivo
for the development of two lymphatic vessel networks that form
through a process of LEC migration and/or vessel sprouting; the
ﬁrst primitive lymphatic vessels in the jugular region20,21 of the
embryo and the lymphatic vasculature of the dorsal skin37. In the
mesentery, where lymphatic vessels form by lymphvasculogenic
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assembly from progenitors47, initial vessel formation is not affected
but valve morphogenesis is inhibited18.
Intriguingly, as opposed to the previously reported activation
of GATA2 in ECs in response to increased mechanical stimu-
lus17,18, we found that GATA2 expression is increased in LECs
upon exposure to a soft matrix and when LECs have left the CV
(i.e. decreased mechanical stimulus and YAP/TAZ signalling).
Moreover, our data suggest that the mechanosensitive transcrip-
tional program activated in LECs in response to different
mechanical stimuli, namely increased matrix stiffness and oscil-
latory ﬂow are remarkably different. It has been described in
several cell types including ECs that GATA2 interacts with other
transcriptional regulators, including Etv248 and Lmo249, to form
multimeric transcription complexes. An interesting possibility
that should be addressed in future studies is whether oscillatory
ﬂow- and soft matrix-induced differences in the GATA2 medi-
ated regulation of target genes and cellular responses is explained
by formation of different transcriptional complexes. Interestingly,
while OSS induces cell cycle arrest in the LECs14, stiff matrix
promotes cell proliferation and adhesion. Yet other mechanical
forces exerted by stretching50 and laminar ﬂow51,52 also increase
LEC proliferation. It should be noted that many of the baseline
behaviors of LECs and other cell types are recorded in in vitro
cultures on plastic or glass, the stiffness of which is in the giga-
pascal range and therefore orders of magnitude stiffer than any
living tissue. For example, the stiffness of embryonic tissue, brain
and liver is only 0.2–0.6 kPa (27 and this study).
Exposure of cultured LECs to a soft matrix of 0.2 kPa, corre-
sponding to the stiffness of embryonic tissue that provides a
substrate for LEC progenitor migration in vivo, led to GATA2-
dependent changes in the expression of several known lymphatic
regulators. Besides VEGFR3, these genes may also contribute to
the lymphatic vascular defects in the Gata2 deﬁcient mice. For
example, FGFR3 that controls early lymphatic vessel develop-
ment53 was upregulated in LECs grown on soft matrix, and
downregulated in Gata2 deﬁcient LECs in vivo. TGFβ2 was
similarly downregulated on soft matrix in a GATA2-dependent
manner, consistent with the previously reported regulation of
TGFβ1 by GATA2 during erythroid differentiation54. TGFβ sig-
nalling has a context-dependent role in lymphatic vasculature and
has been shown to both promote55 and inhibit54 lymphangio-
genesis. A similar bi-functional role during lymphangiogenic
growth has been described for NOTCH signalling. At early stages
of development, NOTCH1 activity limits excessive LEC pro-
liferation35,56. In agreement with this, we found that LECs grown
on soft matrix showed GATA2-dependent upregulation of
NOTCH1 and its downstream targets HEY1/2. GATA2-depen-
dent, soft matrix-induced upregulation of genes controlling valve
morphogenesis, including EphrinB233, integrin α957 and Con-
nexin 3758 may further indicate previously unrecognized
functions of these genes also during the early steps of lymphatic
development.
Cyclic stretching of cells cultured on soft matrix recapitulates
the phenotype of cells grown on stiff matrix, namely stress ﬁber
formation, cell spreading and proliferation59. Interestingly, LEC
stretching, caused by increase in interstitial ﬂuid pressure between
E11.5 and E12.0 of mouse development, was previously shown to
promote integrin ß1-dependent VEGFR3 phosphorylation and
LEC proliferation50. This, together with the data presented in our
study, suggests a stepwise regulation of early lymphatic vascular
expansion by biomechanical signals. First, upon exiting the car-
dinal vein, exposure of LECs to a soft matrix leads to cell cycle
exit and upregulation of genes involved in cell migration (Fig. 7b).
Importantly, GATA2 mediated VEGFR3 upregulation is critically
required for directed VEGF-C-dependent migration of LECs to
establish the primary network of LECs between E10.5-E11. In the
second step (E11.5), increase in the interstitial ﬂuid pressure and
concomitant stretching of LECs stimulate VEGFR3 phosphor-
ylation, LEC proliferation and vessel growth50. In the third step
(E11.5 onwards), ﬂow induced mechanical forces further shape
the developing vasculature. Initiation of (laminar) ﬂow in the
vessels has been shown to promote vessel sprouting through
inhibition of NOTCH1, while KLF2/4 induces proliferation51,52.
Later (from E15 onwards), turbulent ﬂow at vessel branch points
within a primitive vascular plexus induces a FOXC2 and GATA2-
dependent LEC quiescence and valve endothelial
phenotype14,18,19.
Tissue stiffness increases during embryonic development and is
linked to gradual organization and enrichment of collagen
ﬁbers4,60,61. In addition to general stiffening of the tissue, local
changes in matrix stiffness are likely of critical importance. It is
interesting to note that soft, but not stiff matrix has been shown
to precisely regulate cellular functions such as adhesion and
invasiveness in a scale range of 0.1 kPa62, suggesting that small
changes in stiffness in soft (e.g. embryonic) tissues can have
profound effects on cellular behaviors. In the vasculature, the
deposition and assembly of the basement membrane on basal
endothelial surfaces is likely to dramatically change the
mechanical properties of their substrate. It is tempting to spec-
ulate that migrating tip cells leading the vascular sprouts
experience a softer matrix when not supported by the basement
membrane of the vessel wall. Notably, VEGFR3 is highly
expressed in the blood endothelial tip cells63. However, we do not
have evidence for stiffness-regulated expression of GATA2 and
VEGFR3 in either blood or lymphatic vessel sprouts. The ability
of GATA2 to regulate baseline levels of VEGFR3 expression may
instead explain dermal lymphatic vessel sprouting defects in the
Gata2 deﬁcient embryos.
Previous work identiﬁed inactivating mutations in the GATA2
gene as causative of Emberger syndrome, which is an autosomal
Fig. 6 LEC autonomous function of GATA2 in dermal lymphatic vessel sprouting and patterning. a Schematic of the genetic constructs, 4-OHT treatments
(red arrowheads; red bars represent expected time frame of 4-OHT activity) and analyzed embryonic stages. The time frames for pTD+ PLLV and dermal
lymphatic vessel formation are indicated. b Whole-mount immunoﬂuorescence of E15.5 and E17.5 upper thoracic dorsal skins using antibodies against
VEGFR3 (green) and PROX1 (red), or VEGFR3 alone (single channel images on the right). Note reduced VEGFR3 levels in the mutant. c Whole-mount
immunoﬂuorescence of E17.5 upper thoracic dorsal skins using antibodies against PROX1 (green) and LYVE1 (red). Note developing valves consisting of
clusters of highly PROX1 positive cells (arrowheads) that are present in control skin only. d–f Quantiﬁcation of lymphatic vessel diameter (d), branch points
(e) and the distance between contralateral sprouts (open midline; f) in E15.5 and E17.5 dorsal skin in Gata2 mutant (KO) and Cre– littermate control
embryos. Horizontal lines represent mean (n= 16 (E15.5 Ctrl), n= 12 (E15.5 KO), n= 5 (E17.5 Ctrl), n= 11 (E17.5 KO)). p value, unpaired Student’s t-test.
gMorphology of lymphatic vessel sprouts in E17.5 skin. h, i Quantiﬁcation of ﬁlopodia numbers (h) and length (i) in E17.5 dermal lymphatic vessel sprouts.
Horizontal lines represent mean (n= 9 (Ctrl) and n= 10 (KO) embryos), p value, unpaired Student’s t-test. j Quantiﬁcation of LEC nuclei in E17.5 dorsal
skin. Horizontal lines represent mean (n= 4 (Ctrl) and n= 7 (KO) embryos). p value, unpaired Student’s t-test. k Relative mRNA expression levels of the
proliferation markers Mik67 and Ccnb1 in dermal LECs sorted from E15.5 Gata2 mutant (KO; n= 4 or n= 5) and Cre− littermate control (Ctrl; n= 4)
embryos. Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. Scale bars: 100 μm (double-stained images in b, c), 50 μm (single
channel images in b, g)
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dominant condition with lymphedema in lower limbs and geni-
talia29,30. Studies in mice further demonstrated a speciﬁc role of
GATA2 in the formation of lymphatic and lymphovenous
valves18. Lymphatic valve defects are, however, unlikely to fully
explain the early-onset lymphedema and the lack of lymphatic
uptake of intradermally injected tracer in patients with Emberger
syndrome30. Given that a large proportion ( > 30%) of proteins
encoded by hereditary lymphedema-associated genes act on the
VEGF-C-VEGFR3 signalling pathway64, our ﬁnding that GATA2
regulates VEGF-C responsiveness of LECs may provide an
explanation for lymphatic vascular failure caused by GATA2 loss
in Emberger syndrome. It is also interesting to note that chronic
(lymph)edema is often accompanied by tissue stiffening65. Our
results further suggest that targeting tissue stiffness is important
for controlling disease progression and response to (lymph)
angiogenic therapy.
In summary, we demonstrate a hitherto unrecognized role of
ECM stiffness in regulating vascular morphogenesis in vivo. We
further uncover that the mechanosensitive transcriptional pro-
gram activated in LECs in response to matrix stiffness is different
from that induced by oscillatory shear. Given that all cells are
exposed to many different types of mechanical forces (including
shear, matrix stiffness, stretching, pulling, compression), which
are increasingly recognized as key regulators of cell behavior and
fate during development, homeostasis and disease, our ﬁndings
call for further investigation into identifying common and unique
mechanoresponses in ECs and other cell types.
Methods
Mice. Gata2ﬂox66, Tie2-Cre67, Prox1-CreERT268, Vegfr3-CreERT269 and Prox1-
GFP37 mice were previously described. Tie2-Cre+ male mice (Gata2ﬂox/+;Cre+)
were crossed with Gata2ﬂox/ﬂox;Cre- females to avoid inheritance of a null allele
when transmitted through the female germ line. For induction of Cre, 4-OHT was
dissolved in peanut oil (10 mgml−1) and administered to pregnant females by
intraperitoneal injection. For Gata2 gene deletion using Vegfr3-CreERT2 and
Prox1-CreERT2 lines and analysis at embryonic day (E)15.5, four consecutive
injections of 1 mg of 4-OHT were administered daily starting at E11.5. For analysis
at E17.5, an additional injection at E15.5 was performed. The same phenotype was
observed in the Gata2ﬂox/ﬂox;Vegfr3-CreERT2 embryos using three consecutive
injections of 2 mg of 4-OHT at E11.5, E12.5 and E13.5. The morning of vaginal
plug detection was considered as embryonic day 0. All strains were maintained and
analyzed on a C57BL/6 J background (backcrossed minimum 6 times). Experi-
mental procedures were approved by the United Kingdom Home Ofﬁce or the
Uppsala Laboratory Animal Ethical Committee.
Cell culture and in vitro gene deletion using 4-OHT. Human primary dermal
lymphatic endothelial cells (HDLEC from juvenile foreskin, cat. C12216) were
obtained from PromoCell. Cells were seeded on bovine Fibronectin-coated dishes
in complete ECGMV2 medium (PromoCell) supplemented with 25 ng ml−1 of
VEGF-C (R&D Systems). Murine primary dermal lymphatic endothelial cells were
isolated from 10 weeks old Gata2ﬂox/ﬂox;Vegfr3-CreERT2 females. Tails were cut at
the base and transferred into sterile HBSS+ 1% penicillin and streptomycin (PS)
before the skin was removed from the tails and cut into 30 mm long fragments. The
fragments were incubated in 5% dispase (Roche) in PBS for 45 min at 37 °C with
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gentle agitation to separate epidermis from dermis. Dermal fragments were washed
in HBSS+ 1% PS, transferred into collagenase A (1 mgml−1) (Roche) in PBS
solution, ﬁltered and then seeded on 0.5% gelatin-coated dishes69. When cells
reached conﬂuence, they were detached with Accutase, incubated with rat anti-
mouse PECAM1 antibody (Mec13.3, Pharmingen, 4 μg per 30 mm dish) for 45 min
at 4 °C and sorted with Dynabeads conjugated with sheep anti-rat antibodies. One
passage later, cells were sorted again as above using LYVE1 antibody (Aly7,
Abnova, 3 μg per 30 mm dish). Pure dermal LECs were cultured on 0.5% gelatin-
coated dishes and passaged 1:3 after 4 days. In vitro gene deletion was induced by
adding 1–2 µM 4-OHT (Sigma) to the culture medium. All cells were cultured at
37 °C in a humidiﬁed atmosphere with 5% CO2.
RNA interference. Stealth RNAi Duplexes and the corresponding Medium GC
Stealth RNAi Control Duplexes (Invitrogen) were used to knock-down human
GATA2. The GATA2 target sequences used were the following: 5′-CAGAC-
GAGGTGGACGTCTTCTTCAA-3′ (siRNA #1) and 5′-CAGCAAGGCTCGTT
CCTGTTCAGAA-3′ (siRNA #2). Cells were subjected to two consecutive cycles of
transfection 24 h and 48 h after plating, using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions.
In vitro matrix stiffness analysis. To analyze the effects of matrix stiffness,
conﬂuent LECs grown on Fibronectin-coated plastic cell culture dishes were
detached with trypsin-EDTA 0.05% and plated on soft (0.2 kPa) or stiff (4, 8, 12 or
25 kPa) bovine Fibronectin-coated Softwell™ or Softslip™ dishes (Matrigen) for 24 h.
For analysis of the effect of GATA2 knockdown, LECs were subjected to two
consecutive cycles of transfection (day 0 and day 1), seeded on day 2 on soft or stiff
matrices and analyzed 24 h later.
LEC sprouting assay. Conﬂuent murine dermal LECs isolated from Gata2ﬂox/ﬂox;
Vegfr3-CreERT2 mice were detached with trypsin and 1.5 × 106 cells were incubated
with 3000 Cytodex-3 beads (rehydrated in PBS) for 4 h in culture medium sus-
pension at 37 °C. Cell-coated beads were subsequently incubated for 48 h in cell
culture dishes to achieve efﬁcient coating of the bead. During this incubation
deletion of Gata2 was induced by adding 1 µM of 4-OHT (or vehicle, EtOH) to the
culture medium. After 48 h, 4-OHT-supplemented medium was removed and
beads were embedded in a ﬁbrin gel (4 mgml−1). Vehicle or 4-OHT treated LECs
were cultured in the absence or presence of 200 ng ml−1 of VEGF-C (R&D Sys-
tems) for three days, after which the beads were photographed for quantiﬁcation of
sprout numbers and length.
Western blot analysis. Total protein extract was obtained by solubilizing cells in
boiling Laemmli buffer [2.5% SDS and 0.125M Tris-HCl (pH 6.8)]. Cell lysates
were incubated 5 min at 100 °C to induce protein denaturation and then spinned
for 5 min at 16,100 g to discard cell debris. Supernatants were collected and protein
concentration was determined using a BCA™ Protein Assay Kit (Pierce) according
to manufacturer’s instructions. Equal amounts of proteins were loaded on gel and
separated by SDS-PAGE, transferred to a PVDF Membrane 0.2 µm pore size
(BIORAD) and blocked for 1 h at RT in 1 × Tris Buffered Saline Tween (TBST)
[150 mM NaCl, 10 mM Tris-HCl (pH 7.4), and 0.05% Tween] containing 5% w/v
powdered milk. The membranes were subjected to overnight incubation at 4 °C or
1 h at RT with primary antibodies diluted in 1 × TBST-5% BSA. Following this
incubation, membranes were rinsed three times with 1 × TBST for 5 min each and
incubated for 1 h at RT with HRP-conjugated secondary antibodies (diluted in 1 ×
TBST-5% BSA). Membranes were rinsed three times with TBST for 5 min each and
speciﬁc binding was detected using the enhanced chemiluminescence (ECL) system
(Amersham Biosciences) and the Gel Doc™ XR+ System. Protein molecular masses
were estimated relatively to the electrophoretic mobility of co-transferred pre-
stained protein marker, Broad Range (Cell Signaling Technology). The following
primary antibodies were used: rabbit anti-VEGFR3 (cat. SC-321, Santa Cruz Bio-
technology, 0.5 µg ml−1), goat anti-GATA2 (cat. 4595, Cell Signaling Technology,
0.5 µg ml−1) and mouse anti-α-Tubulin (cat. T5168, Sigma-Aldrich, 0.1 µg ml−1).
Full blots are shown in Supplementary Fig. 8.
Flow cytometry. Embryonic tissue from E11 Prox1-GFP+ embryos or E15.5
Gata2ﬂox/ﬂox;Vegfr3-CreERT2 embryos were harvested, dissected in cold PBS and
digested in 4 mgml−1 Collagenase IV (Life technologies), 0.2 mg ml−1 DNaseI
(Roche) and 10% FBS (Life technologies) in PBS at 37 °C for 10–15 min with
vigorous shaking every 5 min. Collagenase activity was quenched by dilution with
FACS buffer (PBS, 0.5% FBS, 2 mM EDTA) and digestion products were ﬁltered
twice through a 70 µm nylon ﬁlter (BD Biosciences). Cells were washed with FACS
buffer and immediately processed for enrichment of CD31 (PECAM1) positive
cells using magnetic beads according to the manufactures instructions (Miltenyi
Biotec). After enrichment, Fc receptor binding was blocked with rat anti-mouse
CD16 (CD32), (cat. 14-0161, eBioscience, 1:100). Samples were thereafter stained
with anti-podoplanin PE (eF660, cat. 50-5381, 1:100) and anti-CD31 (PECAM1)
(390) PE-Cy7 (cat. 25-0311, eBioscience, 1:200). Immune cells and erythrocytes as
well as dead cells were excluded using anti-CD45 (30-F11, cat. 48-0451, 1:50), anti-
CD11b (M1/70, cat. 48-0112, 1:50) and anti-TER-119 e450 (TER-119, cat. 48-5921,
1:50) (all from eBioscience), together with the cell death dye Sytox blue (Life
technologies), all detected by the violet laser as one dump channel. For compen-
sation, the AbC anti-rat/hamster compensation bead kit (Life Technologies) was
used. Cells were sorted on a BD FACSAria III cell sorter equipped with a 85 µm
nozzle and data were processed using FlowJo software (TreeStar). Single cells were
gated from a FSC-A/FSC-H plot followed by exclusion of dead cells and immune
cells and erythrocytes in the violet dump channel. Subsequent gating to obtain cell
fractions to be sorted is presented in Supplementary Fig. 4.
qRT-PCR analysis. For qRT-PCR analysis of human LECs, total RNA was isolated
by RNeasy Mini kit or RNeasy Micro kit (QIAGEN) and 0.5 μg was reverse
transcribed using oligo dT (SuperScript III First-Strand Synthesis System, Invi-
trogen) or SuperScript® VILO cDNA Synthesis Kit according to the manufacturer’s
instructions. For analysis of sorted mouse LECs, total RNA was extracted by
RNeasy Micro kit (QIAGEN) and all obtained RNA was reverse transcribed using
oligo dT (SuperScript III First-Strand Synthesis System, Invitrogen). cDNA was
pre-ampliﬁed using the TaqMan PreAmp Master Mix Kit. Gene expression levels
were analyzed using TaqMan Gene Expression Assay (Applied iBiosystems) and a
7900 HT Fast Real-Time PCR System thermocycler (Applied Biosystems) following
manufacturer’s instructions. Relative gene expression levels were normalized to
GAPDH or the endothelial marker TEK. The following probes were used:
Hs99999905 GAPDH, Hs00176607 FLT4, Hs00216777 ANTXR1, Hs01114113
HEY1, Hs1062014 NOTCH1, Hs01030099 CCNB1, Hs00170014 CTGF,
Hs00932747 TGFBI, Hs00704917 GJA4, Hs00187950 EFNB2, Hs00173317
ANKRD1, Hs00231119 GATA2, Hs00945150 TEK, Hs01554629 ERG, Hs04260396
MIK67, Hs01084593 CCNB2, Hs00942540 MYBL2, Hs01557695_m1 BUB1,
Hs00155479 CYR61, Ms99999915 Gapdh, Ms00492300 Gata2, Ms01292604 Flt4,
Mm00443243 Tek, Mm01214244 Erg, Mm00438670 Efnb2, Mm00433294 Fgfr3,
Mm01278617 Mki67, Mm01171453 Ccnb2.
Microarray expression analysis. Human LECs were treated with control siRNA
or GATA2 siRNA #1 as described above, and cultured on soft (0.2 kPa) or stiff (25
kPa) matrices for 24 h. Total RNA was isolated using the RNeasy Mini kit (QIA-
GEN) and DNA digestion was performed using the RNase-Free DNase Set
(QIAGEN). RNA concentration and quality was evaluated using the Agilent 2100
Bioanalyzer system (Agilent Technologies Inc, Palo Alto, CA). 10 ng of total RNA
starting amount was used to generate ampliﬁed and biotinylated sense-strand
cDNA from the entire expressed genome according to the GeneChip® WT Pico
Reagent Kit User Manual (P/N 703262 Rev 1 Affymetrix Inc., Santa Clara, CA).
GeneChip® ST Arrays (GeneChip® Human Transcriptome Array 2.0) were
hybridized for 16 h in a rotating 45 °C incubator, according to the GeneChip®
Expression Wash, Stain and Scan Manual (PN 702731 Rev 3, Affymetrix Inc., Santa
Clara, CA). The arrays were then washed and stained using the Fluidics Station 450
and ﬁnally scanned using the GeneChip® Scanner 3000 7 G.
The raw data was normalized to gene level in Expression Console, provided by
Affymetrix (http://www.affymetrix.com), using the robust multi-array average
(RMA) method70,71. Subsequent analysis of the gene expression data was carried
out in the statistical computing language R (http://www.r-project.org) using
packages available from the Bioconductor project (www.bioconductor.org). To
identify differentially expressed genes between the ctrl stiff and ctrl soft groups, a
stepwise analysis with 6 biological replicates was performed. First, exon set ID’s
with an average expression lower than 5 were considered as not signiﬁcantly
expressed and excluded from the analysis. A threshold of 40% increase (>0.5 log2
fold change) or decrease (<−0.5 log2 fold change) of gene expression on the soft
matrix (vs. stiff matrix) was considered for further analysis. For all genes with three
or more exon probe set ID’s regulated above the deﬁned thresholds, the average
log2 fold change of the regulated exon probe ID’s was calculated and used to
generate the ﬁnal list of genes regulated by matrix stiffness. 3.8% of the regulated
genes were found to be both increased and decreased, potentially indicating
differential expression of different splice variants. These genes were excluded from
further validations. To identify regulated transcription factors the most updated
database of transcription factors was exported72. Additionally, we employed the
TFactS online module (https://omictools.com/tfacts-tool) to predict the core
transcription factors of stiffness regulation in LECs28. To determine which of the
genes are regulated in a GATA2 dependent manner, a stepwise analysis with 2
biological replicates ctrl siRNA soft vs GATA2 siRNA soft groups was performed.
The previously identiﬁed exon probe ID’s for genes differentially regulated between
the ctrl stiff and ctrl soft groups were extracted and their average log2 fold change
was calculated for the new data set. A threshold of 40% increase (>0.5 log2 fold
change) or decrease (<−0.5 log2 fold change) of gene expression in the absence of
the GATA2 was used to generate the ﬁnal list of genes.
To compare gene expression changes in LECs exposed to oscillatory shear stress
(OSS), we utilized microarray data from a previously published study14. Processed
array data were downloaded from NCBI GEO database (accession number:
GSE60152) and the four control siRNA treated samples, representing two replicates
for both static and OSS conditions, were used for analysis. Same array ﬁltering
criteria were applied as above, including the exclusion of probe sets with average
expression lower than ﬁve from the analysis. The average fold changes between
LEC expression levels under OSS vs static conditions were calculated. 544 genes
showing increased expression (>0.5 log2 fold change) and 826 genes showing
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decreased expression (<−0.5 log2 fold change) were compared with matrix stiffness
regulated genes.
The online tool of the Gene Ontology Consortium (PANTHER
Overrepresentation Test, release 20160715) was used to determine signiﬁcantly
enriched GO terms from a group of genes. The Bonferroni correction for multiple
testing was applied and GO terms with p < 0.05 were included. For visualization of
regulated GO terms and associated genes the Cytoscape software was employed.
For visualization of Venn diagrams, the BioVenn web application was employed.
Immunoﬂuorescence. For whole-mount immunostaining, tissues were ﬁxed in 4%
paraformaldehyde (PFA) for 2 h at RT or overnight at 4 °C, permeabilised in 0.3%
Triton-X100 in PBS (PBSTx) and blocked in PBSTx plus 3% milk (blocking buffer).
Primary antibodies were incubated at 4 °C overnight in blocking buffer. After
washing in PBSTx, the samples were incubated with ﬂuorocrome-conjugated sec-
ondary antibodies in blocking buffer, before further washing and mounting in
Mowiol or Dako Fluorescence Mounting Medium. For visualization of cardinal
veins and lymph sacs, 150 μm vibratome cross sections of E11.5 wild type or E12.5
Tie2-Cre embryos or 10 μm cryo-sections from E11 Prox1-GFP embryos were used
for staining as described above. For staining of primary LECs, cells were ﬁxed with
4% PFA in PBS for 20 min at RT and permeabilized using 0.5% Triton-X100 in
PBS for 5 min at RT followed by blocking with 3% BSA in PBSTx for 1 h. Primary
antibodies were incubated for 1 h at RT, washed twice with PBSTx and subse-
quently incubated with secondary antibodies for 45 min at RT before further
washing and mounting in Dako Fluorescence Mounting Medium. The following
antibodies were used: rabbit anti-GATA2 (cat. NBP1-82581, Novus Biologicals,
1:1000), rabbit anti-GATA2 (cat. sc-9008, Santa Cruz Biotechnology, 1:200), goat
anti-VE-cadherin (C19, cat. sc-6458, Santa Cruz Biotechnology, 2 µg ml−1), goat
anti-LaminB (M20, cat. sc-6217, Santa Cruz Biotechnology, 1:300), rabbit anti-
Collagen I (cat. ab34710, Abcam, 1 µg ml−1), rat anti-LYVE1 (cat. MAB2125, R&D
Systems, 1:100), rabbit anti-LYVE1 (cat. 103-PA50AG, RELIATech GmbH, 1:100),
goat anti-Neuropilin2 (cat. AF567, R&D Systems, 1:200), hamster anti-Podoplanin
(clone 8.1.1., Developmental Studies Hybridoma Bank, 1:1000), rabbit anti-
PROX137 (1:200), goat anti-PROX1 (cat. AF2727, R&D Systems, 1:200), goat anti-
VEGFR3 (cat. AF743, R&D Systems, 1:200), rat anti-Endomucin (cat. sc-65495,
Santa Cruz Biotechnology, 1:500). Secondary antibodies conjugated to AF488, Cy2,
Cy3 or Cy5 were obtained from Jackson ImmunoResearch (all used 1:200).
Additionally, DAPI (D9542, Sigma Aldrich) and Alexa Fluor® 568 Phalloidin
(A12380, ThermoFisher Scientiﬁc) were used. Whole-mount immunostaining for
light sheet microscopy was performed as previously described20. In brief, Anti-
PECAM1 (clone 5D2.6 and 1G5.279, 20 µg ml−1), anti-VEGFR3 (cat. AF743, R&D
Systems, 15 µg ml−1) and anti-PROX1 (cat. 102-PA32, RELIATech GmbH, 1:200)
were diluted in PermBlock. For visualization, embryo wholemount stainings were
embedded in 1% low‐melting point agarose. After dehydration in methanol (50, 70,
95, 100, 100% methanol, each step 30 min), samples were twice optically cleared in
a benzyl alcohol:benzyl benzoate solution (BABB, ratio 1:2 (v/v)) for 4 h each.
Image acquisition. Confocal images of tissues and cells represent maximum
intensity projections of Z-stacks that were acquired using Zeiss LSM 780 confocal
microscope with Plan Apochromat DIC 10 × /0.45 NA or Plan Apochromat DIC
40 × /1.3 NA objectives and Zeiss Imager.Z2 and Zen 2012 software, or Leica SP8
inverted microscope with HCX PL APO CS 10 × /0.40 DRY, Fluotar VISIR 25 × /
0.95 water or HC PL APO CS2 63 × /1.30 GLYC objectives and Leica LAS-X
software. Stereomicroscope images of embryos were acquired with Nikon
SMZ1500 stereomicroscope equipped with a DS-5M Nikon camera.
BABB-cleared embryos were imaged using a LaVision UltraMicroscope II.
Stacks were captured with a step size of 1 μm at different magniﬁcations. 3D
reconstruction and analysis of ultramicroscopy stacks were performed using the
volume visualization framework Voreen (volume rendering engine)73.
Image quantiﬁcation. All quantiﬁcations were done using Fiji ImageJ unless
differently stated. For Collagen I immunostaining pixel intensity measurements,
corrected total cell ﬂuorescence= integrated density− (area of selected cell × mean
ﬂuorescence of background readings) was automatically calculated (ﬁve images per
embryo, 10–45 measurements per image from maximum intensity projection
images of 36 μm z-stacks from two wild type E11 embryos). Nuclear circularity was
measured from LaminB stained vibratome sections of two wild type E11 embryos.
LaminB immunostaining of the nucleus was analyzed and compared between
Endomucin positive ECs in the venous vessel wall to Endomucin negative cells
outside the vessel wall (two embryos and two images per embryo, 7–10 mea-
surements per single plane image in cells within and outside the vessel wall). For
quantiﬁcation of GATA2 staining intensity in transverse cryo sections of three E11
embryos, IMARIS software was used to create a 3D surface mask based on Prox1-
GFP expression that was used to extract GATA2 and VEGFR3 pixel intensities of
LECs within (4 images per embryo, 3–4 cells per image) and outside of the CV (5
images per embryo, 2–3 cells per image), from maximum intensity projection
images of 50–100 z-stacks. For quantiﬁcation of GATA2 staining intensity in
human LECs grown on soft or stiff matrix, the GATA2 antibody (Novus Biolo-
gicals, NBP1-82581), that has previously been shown to speciﬁcally recognize
GATA2, was used18. From 3 experiments cell coverage was determined by a
deﬁned threshold and pixel intensities were measured for n= 8 images with 8–24
cells per image (total 131 cells) on soft matrix, and for n= 8 images with 21–37
cells per image (total n= 232 cells) on stiff matrix, and the average pixel intensity
value for each image was plotted. To distinguish cytoplasmic and nuclear pixel
intensities, DAPI staining was used to generate a nuclear mask and subtracted from
the overall pixel intensity of each image. For quantiﬁcation of the number and
length of LEC sprouts in the ﬁbrin gel bead assay, 20–30 beads from two inde-
pendent experiments were analyzed for each condition. Quantiﬁcation of lym-
phatic vessel parameters (sprouting, diameter, branching, number of cells and
ﬁlopodia) from whole-mount stained tissue was done using maximum intensity
projection images of tile scanned E15.5 and E17.5 skin samples (xy= 3400 μm×
1700 μm, upper thoracic region). For measurement of the distance of lymphatic
sprouts from the midline (i.e. open midline), dorsal midline was marked with a line
and 5–8 measurements, 2–4 on each side of the midline, were taken from each
image. Lymphatic vessels closest to the midline were always included. Vessel dia-
meter was determined by measuring the thickest part of each vessel segment in
between branch points. 22–47 measurements were taken from each skin samples.
All branch points in each image were marked using Photoshop CS5 software and
counted manually. Filopodia were quantiﬁed from Nrp2 stained lymphatic vessels
tips (150 μm, n= 3–4 tips per embryo) in the sprouting front area. All ﬁlopodia
were marked using Photoshop CS5 software and counted manually. Filopodia
length was measured using Fiji ImageJ. Quantiﬁcation of LEC numbers was done
using CellProﬁler Software (http://www.cellproﬁler.org/). The pipeline included 1
major step: Identiﬁcation of primary objects. LECs nuclei were identiﬁed and
counted based on PROX1 staining. Resulting overlay images of the identiﬁed
objects were saved and checked independently to verify accuracy.
Ex vivo atomic force microscopy. E11 Prox1-GFP embryos were chopped into
350 µm transverse slices with the McIllwain Tissue Chopper (Stoelting). Highest
blade force and lowest chopping speed was used. Slices were carefully separated
from each other with 27 gauge needles and transferred in PBS with a 3.5 ml transfer
pipette (Sarstedt) and low suction to prevent tissue distortion. Tissue slices with
relevant embryonic structures were transferred on Grade 105 Whatman Lens
Cleaning Tissue (GE) ﬂoating on PBS. Whatman paper and the attached tissue slice
were subsequently dried for 30 s on an absorbing tissue before it was transferred to
a force spectroscopy suitable polypropylene culture dish that was covered with a
thin layer of ﬂuid 40 °C low melting agarose (6% in PBS). After 1 min the agarose
solidiﬁed and the embryo tissue slice was ﬁxed from underneath (through the
Whatman paper) in the cell culture dish to allow tissue indentation measurements.
Prior to force spectroscopy, the position of Prox1-GFP positive structures (cardinal
vein and future primary lymphatic plexus area) and other features of interest were
located using an upright ﬂuorescence microscope (Nikon ME600) equipped with a
mercury lamp and ﬂuorescence camera (SPOT RT Monochrome, Diagnostic
Instrument Inc, USA). After mounting in the atomic force microscope (JPK
Nanowizard 3 with top-view optics, JPK Instruments, Berlin), force spectroscopy
was performed after locating the measurement position via the top-view optics. To
maximize the chance of landing on the correct area based on the ﬂuorescence
image, a matrix of 3 × 3 force spectroscopy points was set up over a 10 × 10 μm
area. Account was taken of the cantilever angle (10°) and a form factor for v-shaped
cantilevers. Calibration of the deﬂection sensitivity in liquid was performed by
recording force ramps against a bare Petri dish in PBS buffer. The bare dish was
then replaced with dishes containing the ﬁxed embryo slices in PBS buffer for
measurement of tissue stiffness via indentation (n= 10 measurements from one
embryo (CV) and n= 114 (outside CV) measurements from three embryos). Five
force ramps were performed at each position of a 3 × 3 point matrix over an area of
10 × 10 μm. A force setpoint of 5 nN and approach/retract speed of 2 μm s−1 was
used and the scan range was set to between 1 and 14 μm depending on the range of
the forces measured. The Hertz indentation model was ﬁtted to each approach
curve to provide an effective Young’s Modulus using the JPK Data Processing
software. This was done by ﬁrst correcting the measured curves for baseline
position and slope, and then converting them to force versus separation curves.
The model was ﬁtted using square pyramidal indenter geometry, with an average
edge angle of 25°. The values of Young’s modulus determined via AFM should not
be considered as quantitative absolute values because of the assumptions made in
the Hertz model—namely that the indenter velocity is very low with respect to the
indentation depth, and that the material is homogeneous and elastic (living cells are
highly heterogeneous and dynamic structures). Force spectroscopy is a “quasi-
static” technique, where the constant motion of the probe can give rise to viscous
damping, which is difﬁcult to accurately account for. However, as the same probe
and indentation conditions were used for all measurements, the results obtained
can be compared with each other to provide an effective Young’s modulus where
viscous damping may make some contribution to the measured value.
Chromatin Immunoprecipitiation. Human LECs were harvested and processed
for ChIP using a truChIP™ Low Cell Chromatin Shearing Kit with SDS Shearing
Buffer (Covaris). Brieﬂy, 10 million cells per ml were cross-linked using 1% for-
maldehyde for 5 min, neutralized with glycine, lysed and nuclei washed. Sheared
chromatin from 10million cell equivalents was immunoprecipitated with 15 μg
rabbit anti-GATA2 antibody (H-116 × , cat. sc-9008; Santa Cruz Biotechnology).
Following washing and reversal of crosslinks, DNA was puriﬁed using a Qiagen
MinElute PCR Puriﬁcation Kit. ChIP-Seq library preparation and sequencing was
carried out at the ACRF Cancer Genomics Facility, Center for Cancer Biology,
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Adelaide. ChIP-Seq libraries were prepared according to Illumina’s TruSeq Sample
Prep Guide Revision A with some minor modiﬁcations. Brieﬂy, DNA was end-
repaired, followed by adenylation of the 3′ ends. Next, Illumina indexing adapters
were ligated to the DNA. 18 cycles of PCR were performed to enrich for suc-
cessfully adapter ligated molecules. Ligation products were puriﬁed with a 2%
Pippin Prep gel (Sage Science), selecting a size range of 250–300 base pairs. The
size distribution and yield of the puriﬁed libraries were determined using an
Agilent Bioanalyzer High Sensitivity chip and Qubit dsDNA HS assay (Invitrogen),
respectively. Libraries were pooled in equimolar ratios and sequenced in one lane
of a HiSeq 2500 short read ﬂowcell (1 × 50 bp). Reads were mapped to the UCSC
hg19 genome with BWA (71) version 0.7.9a-r786, allowing at most three align-
ments. Read depth was calculated via genomeCoverageBed from BEDTools, using
the scale parameter to normalize to reads per million. Read depth was plotted
relative to annotated transcription start sites via custom Python scripts utilizing
Matplotlib.
Statistics. GraphPad Prism was used for graphic representation and statistical
analysis of the data. We used 2-tailed unpaired Student’s t-test to compare between
two means, assuming equal variance; One-sample t-test to compare sample mean
with a normalized control value= 1 (Figs. 2a, b, 3a, 5b, c, e); and Fisher’s exact test
to determine association between two categorical variables (Fig. 5g). Differences
were considered statistically signiﬁcant when p < 0.05. The experiments were not
randomized. No blinding was done in the analysis and quantiﬁcations.
Data availability. All relevant data are available from the corresponding author
upon request. RNA microarray data that support the ﬁndings of this study have
been deposited in GEO (Gene Expression Omnibus) repository with the accession
code GSE110726.
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